GKB Ophthalmics Board Meeting on Nov 12 to Approve Unaudited Results

GKB Ophthalmics Ltd has announced that its Board of Directors will convene on November 12, 2026. The primary agenda item is to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The company has also informed that the trading window for designated persons will reopen 48 hours after the submission of these financial results to the stock exchange. The notice is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.